Beta-1 selective blocker salt form API in extended-release formulations for cardiac arrhythmia and myocardial infarction prophylaxis. Distributed by intermediate suppliers to tablet press operators in GMP-certified plants. Acquired by procurement teams for integration into regimens prescribed by cardiovascular specialists.